Lista de obras - Piotr Adamski - Dominio Público Uruguay

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

artículo científico publicado en 2021

ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial

artículo científico publicado en 2021

Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint

artículo científico publicado en 2017

Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-centre cohort.

artículo científico publicado en 2016

Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.

artículo científico publicado en 2017

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

artículo científico publicado en 2017

Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: a subanalysis of the COV-HF-SIRIO 6 study

Comparison of temperature measurements in esophagus and urinary bladder in comatose patients after cardiac arrest undergoing mild therapeutic hypothermia

scientific article published on 24 September 2018

Dermatomyositis associated with gastrointestinal malignancies - report of two cases and a literature review

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor

artículo científico publicado en 2019

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor

artículo científico publicado en 2022

Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations

artículo científico publicado en 2018

IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study

artículo científico publicado en 2022

Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study)

artículo científico publicado en 2022

Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest

artículo científico publicado en 2019

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors

artículo científico publicado en 2016

Impact of ticagrelor administration strategy on its pharmacokinetics and pharmacodynamics in patients with unstable angina pectoris: a protocol of a randomized study

artículo científico publicado en 2016

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study

artículo científico publicado en 2022

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial

artículo científico publicado en 2015

Leczenie antyagregacyjne u pacjentów z ostrym zespołem wieńcowym — zalecenia dla zespołów ratownictwa medycznego. Stanowisko ekspertów

artículo científico publicado en 2017

Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study

artículo científico publicado en 2022

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

artículo científico publicado en 2022

Metabolism of ticagrelor in patients with acute coronary syndromes

artículo científico publicado en 2018

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial

artículo científico publicado en 2015

New directions for pharmacotherapy in the treatment of acute coronary syndrome.

artículo científico publicado en 2016

Off-target effects of glycoprotein IIb/IIIa receptor inhibitors

artículo científico

Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors

artículo científico publicado en 2014

PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection

Pharmacodynamic and clinical efficacy of reduced ticagrelor maintenance doses in patients with coronary artery disease

scientific article published on 19 November 2020

Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers

artículo científico publicado en 2021

Platelet Reactivity in the Exacerbation of Psoriasis

artículo científico publicado en 2024

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study

artículo científico publicado en 2019

Polish trials influencing 2017 European Society of Cardiology guidelines on acute myocardial infarction in patients presenting with ST-segment elevation.

artículo científico publicado en 2017

Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022

artículo científico publicado en 2022

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

artículo científico publicado en 2020

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study

artículo científico publicado en 2017

Reversal of Platelet Inhibition in Patients Receiving Ticagrelor

artículo científico publicado en 2022

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing

scientific article published on 03 December 2019

Sweet's syndrome with idiopathic epididymitis

artículo científico publicado en 2017

Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint

scientific article published on 19 April 2018

Unilateral generalized morphea: a case report and literature review

scholarly article published August 2018

Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite? The HARMONIC study.

artículo científico publicado en 2016

Lista de obras de Piotr Adamski

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial

Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint

Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-centre cohort.

Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: a subanalysis of the COV-HF-SIRIO 6 study

Comparison of temperature measurements in esophagus and urinary bladder in comatose patients after cardiac arrest undergoing mild therapeutic hypothermia

Dermatomyositis associated with gastrointestinal malignancies - report of two cases and a literature review

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor

Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations

IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study

Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study)

Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors

Impact of ticagrelor administration strategy on its pharmacokinetics and pharmacodynamics in patients with unstable angina pectoris: a protocol of a randomized study

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial

Leczenie antyagregacyjne u pacjentów z ostrym zespołem wieńcowym — zalecenia dla zespołów ratownictwa medycznego. Stanowisko ekspertów

Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

Metabolism of ticagrelor in patients with acute coronary syndromes

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial

New directions for pharmacotherapy in the treatment of acute coronary syndrome.

Off-target effects of glycoprotein IIb/IIIa receptor inhibitors

Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors

PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection

Pharmacodynamic and clinical efficacy of reduced ticagrelor maintenance doses in patients with coronary artery disease

Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers

Platelet Reactivity in the Exacerbation of Psoriasis

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study

Polish trials influencing 2017 European Society of Cardiology guidelines on acute myocardial infarction in patients presenting with ST-segment elevation.

Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study

Reversal of Platelet Inhibition in Patients Receiving Ticagrelor

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing

Sweet's syndrome with idiopathic epididymitis

Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint

Unilateral generalized morphea: a case report and literature review

Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite? The HARMONIC study.